Skip to main content
Clinical Trials/NL-OMON32007
NL-OMON32007RecruitingNot Applicable

Expiratory airflow limitation in subjects with obesity - Obesity and EF

Medisch Centrum Alkmaar0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Inclusion criteria obese population:;Male/female, age 25-60
  • BMI (body mass index) 30-40 kg/m2
  • Non or ex smokers with < 10 packyears;Inclusion criteria control population:;Male/female, age 25-60
  • BMI (body mass index) 18.5-25 kg/m2
  • Non or ex smokers with <10 packyears

Exclusion Criteria

  • COPD (FEV1/IVC<0.70)
  • reversibility >9% in FEV1 (400 microgram salbutamol)
  • other significant neuromuscular, cardiac or lung disease;Exclusie criteria controle population:
  • COPD (FEV1/FVC<70)
  • any other significant neuromuscular, cardial of pulmonary disease
  • reversibility >9% in FEV1 (400 microgram salbutamol);Exclusion criteria control population:
  • No COPD (FEV1/FVC<70)
  • No other significant neuromuscular, cardiac or lung disease
  • No reversibility >9% in FEV1 (400 microgram salbutamol)

Investigators

Sponsor
Medisch Centrum Alkmaar

Similar Trials

Expiratory airflow limitation in subjects... | Clinical Trial